Prelude Therapeutics (PRLD) Capital Expenditures (2019 - 2025)
Prelude Therapeutics (PRLD) reported Capital Expenditures of $20000.0 for Q2 2025, down 94.43% on a YoY basis from $359000.0 in Q2 2024, and down 57.45% sequentially from $47000.0 in Q1 2025.
Prelude Therapeutics (PRLD) Capital Expenditures (2019 - 2025) Analysis & Trends
Prelude Therapeutics (PRLD) has 7 years of Capital Expenditures data on file, last reported at $20000.0 in Q2 2025.
- For the quarter ending Q2 2025, Capital Expenditures fell 94.43% year-over-year to $20000.0; the trailing twelve-month figure through Mar 2026 stood at $20000.0 (up 108.62% YoY), and the FY2025 full-year result was $67000.0, up 570.0% from the prior year.
- Capital Expenditures declined to $20000.0 in Q2 2025, from $47000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.6 million in Q3 2021 to a low of -$1.4 million in Q3 2022.
- A 5-year average of $249222.2 and a median of $321500.0 in 2022 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 2887.88% in 2021, while the deepest fall reached 774.16% in 2021.
- Tracing PRLD's Capital Expenditures over 5 years: stood at -$1.2 million in 2021, then surged by 80.9% to -$233000.0 in 2022, then soared by 584.55% to $1.1 million in 2023, then sank by 162.09% to -$701000.0 in 2024, then soared by 102.85% to $20000.0 in 2025.
- Business Quant data shows PRLD's Capital Expenditures at $20000.0 in Q2 2025, $47000.0 in Q1 2025, and -$701000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Mar 31, 2024 | 289,000.00 |
| Mar 31, 2024 | 289,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 591,000.00 |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | 983,000.00 |
| Jun 30, 2023 | 983,000.00 |
| Mar 31, 2023 | 810,000.00 |
| Mar 31, 2023 | 810,000.00 |